stockrow
Saturday 7 November 2026
Export PPBT’s income statement to Excel — free account
Purple Biotech Ltd. Sponsored ADR
PPBT Healthcare Biotechnology
- EPS
- +110.2%
- Free cash flow
- −62.1%
Quarter to June 2026, against a year earlier
1.28
0.03
+2.40%
Follow PPBT
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.73 | 1.23 | 1.40 | 3.42 | |
Current Ratio |
1.78 | 1.27 | 1.48 | 3.70 | |
Net Debt/EBITDA |
7.99 | 0.41 | 2.94 | 4.97 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 0.05 | 36.29 | (5.68) | |
Capex/Depreciation |
0.14 | (0.17) | 0.00 | (0.04) | |
Interest Coverage |
(273.40) | (24.89) | (72.61) | (144.33) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.71 | 0.42 | 0.51 | 0.52 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.34) | (2.22) | (3.35) | (2.30) | |
Capex per Share |
0.02 | (0.02) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.32) | (2.24) | (3.35) | (2.31) | |
Cash per Share |
22.95 | 19.94 | 6.90 | 5.62 | |
Shareholders Equity per Share |
72.04 | 20.12 | 10.38 | 11.25 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
72.04 | 20.12 | 10.38 | 11.25 | |
Free Cash Flow |
(1.06) | (1.08) | (3.12) | (2.51) | |
Working Capital |
4.72 | 2.11 | 2.19 | 4.81 | |
Capital Expenditures |
0.01 | (0.01) | — | 0.00 | |
Net Current Asset Value |
4.53 | 1.95 | 2.03 | 4.64 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
| Other line items | |||||
Average Payables |
1.26 | 1.76 | 0.86 | 0.58 | |
Average Assets |
37.08 | 27.31 | 25.01 | 24.27 | |
Average Common Equity |
31.14 | 21.29 | 21.18 | 22.13 |
Columns are period end dates · fundamentals updated 26 Oct 2026